Health
Life-extending drug for incurable breast cancer approved for NHS use – The Guardian
About 3,300 women a year may benefit from decision to approve ribociclib
Breast cancerAbout 3,300 women a year may benefit from decision to approve ribociclib
Fri 26 Feb 2021 08.57 EST
Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance.
The National Institute for Health and Care Excellence (Nice) has approved the drug ribociclib , also known as Kisqali for routine use by the NHS in England and Wales. It said around 3,300 women a year with advanced breast…
-
Noosa News20 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business24 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
General11 hours agoDefence minister won’t say if security agencies or Trump administration pushed for Darwin Port backflip
-
General8 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A